Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01689038 · ClinicalTrials.gov registry record · Phase 1
Brain Imaging Study of F17464
A Phase 1 study, sponsored by Pierre Fabre Medicament.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01689038 is a Phase 1 study that has completed, run by Pierre Fabre Medicament. The registered enrollment target is 8 participants.
The verdict
NCT01689038, a Phase 1 study, has completed, sponsored by Pierre Fabre Medicament.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Assess the binding rate of F17464 to cerebral receptors in healthy volunteers.
Interventions
- DRUG F17464
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01689038
The ClinicalTrials.gov registry entry for NCT01689038 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pierre Fabre Medicament, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which F17464 is the first listed.
NCT01689038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01689038 about?
NCT01689038 is a clinical study titled "Brain Imaging Study of F17464". Assess the binding rate of F17464 to cerebral receptors in healthy volunteers.
What is the current status of trial NCT01689038?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2012-11. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01689038?
The interventions under investigation include: F17464 (DRUG).
Who is sponsoring clinical trial NCT01689038?
This trial is sponsored by Pierre Fabre Medicament, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.